Биспонса
Active substance: inotuzumab ozogamicin
лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 1 мг, (original in Russian, GRLS)
RussiaActive
Marketing holder: Пфайзер Инк.
Verified 2026-10-09 · GRLS (Russian state register)
Analogues in other countries- Source: GRLS (Russian state register)
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| US 1 |
|
| EU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-35c1-7bd1-892a-dfb4dc30d5f3,01a120c5-d710-7379-9254-094ece38cc4f;count=2 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-a9e6-7da2-8932-fe82734b79be;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- ЛП-005883
- Registration status
- Active
- Dispensing
- Prescription only
- Release forms
- лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 1 мг, - флаконы - пачки картонные - По рецепту; (original in Russian, GRLS)
Sources
- product · GRLS (Russian state register) · ЛП-005883 · Verified 2026-10-09
- registration_status · GRLS (Russian state register) · ЛП-005883 · Verified 2026-10-09
- ingredients.0 · GRLS (Russian state register) · ЛП-005883 · Verified 2026-10-09